MPG.eBooks - Description: Atypical antipsychotics for schizophrenia

Cover Image

Read Now

Atypical antipsychotics for schizophrenia combination therapy and high doses

The objective of this study was to identify and appraise the clinical evidence pertaining to use of atypical antipsychotics combination therapy and high-dose treatment strategies in adolescents and adults with schizophrenia

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa, ON Canadian Agency for Drugs and Technologies in Health December 2011, 2011
Series:	Optimal use report
Subjects:	Schizophrenia / Drug Therapy Antipsychotic Agents / Therapeutic Use Combined Modality Therapy / Methods
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK169697
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The objective of this study was to identify and appraise the clinical evidence pertaining to use of atypical antipsychotics combination therapy and high-dose treatment strategies in adolescents and adults with schizophrenia
Item Description:	Title from PDF title page. - Accompanied with: Current utilization of antipsychotic agents for schizophrenia : combination and high-dose therapies / prepared by Canadian Agency for Drugs and Technologies in Health. Optimal use report ; volume 1, issue 1E.
Physical Description:	1 PDF file (ii, 199, ii, 30 pages) illustrations